Clinical Trials
4 trialsNCT06866964 2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT05920343 2025-07-10
PREVENT-GU
Ottawa Hospital Research Institute
Phase 2/3 Recruiting
NCT03006562 2020-08-05
PREVENTER
Johns Hopkins University
Phase 4 Terminated
NCT01325558 2016-07-15
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
Phase 1 Completed